Nested Therapeutics, a clinical-stage oncology company developing transformative therapies for RAS/MAPK-driven disorders, today reported initial clinical results from its ongoing Phase 1 study ...

Nested Therapeutics, a Versant Ventures-backed biotech creating a next-gen precision medicine platform to focus on hard-to-treat cancers, announced the close of a $90 million Series A financing round ...

Understanding the role of certain proteins and mutations has paved the way for many cancer therapies, but in some cases knowing the target and its role is not enough for scientists to be able to find ...